Evolent Health Inc (EVH) — Capital Reinvestment Ratio
Latest as of December 2025:
0.16x
Evolent Health Inc (EVH) has a Capital Reinvestment Ratio of 0.16x as of December 2025, meaning it reinvests 0% of its operating cash flow ($48.80 Million) in capital expenditures ($7.76 Million). See EVH free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.16x
Capex / Operating Cash Flow
Operating Cash Flow
$48.80 Million
USD
Capital Expenditures
$7.76 Million
USD
Data as of
Dec 2025
Most recent filing
Evolent Health Inc Capital Reinvestment Ratio (2021–2025)
This chart tracks Evolent Health Inc's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Evolent Health Inc (2021–2025)
Year-by-year Capital Reinvestment Ratio for Evolent Health Inc from 2021 to 2025. For live market cap and broader valuation context, see how much is Evolent Health Inc worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.88x | $38.84 Million | $34.09 Million | ▼ -33.8% |
| 2024 | 1.33x | $18.77 Million | $24.89 Million | ▲ +558.0% |
| 2023 | 0.20x | $142.58 Million | $28.75 Million | ▼ -68.7% |
| 2021 | 0.64x | $38.75 Million | $24.98 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow